Covid-19: Pfizer eyes emergency use approval for vaccine in November



Pfizer had said previously that it expected late-stage trial data in October.

Pfizer Inc said on Friday it could apply for US emergency use of its Covid-19 vaccine candidate being developed along with Germany’s BioNTech SE as soon as a safety milestone is achieved in the third week of November.

The US Food and Drug Administration has said it wants at least two months of safety data before authorizing emergency use of any experimental coronavirus vaccine.

Based on current trial enrollment and dosing pace, Pfizer expects to have that safety data in the third week of November, Chief Executive Officer Albert Bourla said in a statement.

READ MORE  Diplomat Mustapha Adib designated as Lebanon's new Prime Minister

Pfizer had said previously that it expected late-stage trial data in October.






Source link

Advertisement

Be the first to comment

Leave a Reply